[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Curated health policy research and original commentary from across the JAMA Network
[Skip to Content Landing]
Editor's Comment

Coronavirus and Health Policy: A JAMA Network Interview

  • 1Editor, JAMA Health Forum
  • 2Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor
  • 3Deputy Editor, JAMA Health Forum
  • 4Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee

When JAMA Health Forum launched 3 months ago, our inaugural Editor’s Comment welcomed readers around the world to this new web-based JAMA Network channel for health policy content. We shared our goal for the new channel “to serve as a timely, engaging, and influential venue for authors and readers to connect on the most important issues facing health care systems in the United States and other countries.”1 At that time, the local outbreak of a novel coronavirus in Wuhan, China, was just beginning to emerge as a focus of global concern.

Last week we joined Howard Bauchner, MD, JAMA editor in chief, for an interview on coronavirus and health policy. During the short period between the launch of JAMA Health Forum and today, many countries have been overwhelmed by the coronavirus disease 2019 (COVID-19) pandemic, with nearly 2.4 million confirmed cases and more than 165 000 deaths worldwide by April 19. As the pandemic has accelerated since mid-March, JAMA Health Forum has published many insightful commentaries on a broad range of health policy topics related to COVID-19, including the following widely read articles:

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words